$17.00
$-0.09 (-0.53%)
End-of-day quote: 05/10/2024
NYSE:CLB
Core Laboratories Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$509.79M | $489.74M | $470.25M | $487.27M | $668.21M | $700.85M | $794.65M | |
| GM % | Gross Margin % |
|
21.54% | 19.62% | 21.77% | 20.96% | 25.83% | 29.09% | 35.34% | |
| OM | Operating Margin |
|
11.06% | 8.79% | 8.78% | 10.18% | 15.27% | 17.10% | 28.59% | |
| EPS | Earnings Per Share |
|
$0.00 | $0.80 | $0.57 | $0.71 | $0.79 | $1.78 | $2.08 | $3.02 |
| Div. | Dividends |
|
$0.04 | $0.04 | $0.04 | $0.28 | $2.20 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
5.00% | 7.02% | 5.63% | 35.44% | 123.60% | 0 | 0 | |
| Sha. | Shares |
|
46.86m | 46.63m | 46.35m | 44.57m | 44.47m | 44.32m | 45.52m | |
| OCF | Operating Cash Flow |
|
$24.79M | $24.96M | $36.58M | $57.87M | $89.53M | $111.83M | $205.83M | |
| FCF | Free Cash Flow |
|
$35.05M | $14.74M | $23.04M | $45.99M | $67.26M | $90.09M | $178.26M | |
| FCFS | Free Cash Flow Per Share |
|
$0.31 | $0.32 | $0.49 | $1.02 | $1.51 | $2.01 | $3.97 |
